Literature DB >> 28963914

Quality indicators in breast cancer care: An update from the EUSOMA working group.

Laura Biganzoli1, Lorenza Marotti2, Christopher D Hart3, Luigi Cataliotti4, Bruno Cutuli5, Thorsten Kühn6, Robert E Mansel7, Antonio Ponti8, Philip Poortmans9, Peter Regitnig10, Jos A van der Hage11, Yvonne Wengström12, Marco Rosselli Del Turco13.   

Abstract

In 2010, EUSOMA published a position paper, describing a set of benchmark quality indicators (QIs) that could be adopted by breast centres to allow standardised auditing and quality assurance and to establish an agreed minimum standard of care. Towards the end of 2014, EUSOMA decided to update the paper on QIs to consider and incorporate new scientific knowledge in the field. Several new QIs have been included to address the need for improved follow-up care of patients following primary treatments. With regard to the management of elderly patients, considering the complexity, the expert group decided that, for some specific quality indicators, if centres fail to meet the minimum standard, older patients will be excluded from analysis, provided that reasons for non-adherence to the QI are specified in the clinical chart and are identified at the review of the clinical records. In this way, high standards are promoted, but centres are able to identify and account for the effect of non-standard treatment in the elderly. In the paper, there is no QI for outcome measurements, such as relapse rate or overall survival. However, it is hoped that this will be developed in time as the databases mature and user experience increases. All breast centres are required to record outcome data as accurately and comprehensively as possible to allow this to occur. In the paper, different initiatives undertaken at international and national level to audit quality of care through a set of QIs have been mentioned.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Breast cancer care; Quality indicators

Mesh:

Year:  2017        PMID: 28963914     DOI: 10.1016/j.ejca.2017.08.017

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  40 in total

1.  The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.

Authors:  Francesca Tamburelli; Riccardo Ponzone
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  Revisiting the modern toolkit to optimize breast conservation surgery.

Authors:  David M Lesniak; Krishna B Clough; Brigid K Killelea
Journal:  Gland Surg       Date:  2020-04

Review 3.  Innovative Standards in Oncoplastic Breast Conserving Surgery: From Radical Mastectomy to Extreme Oncoplasty.

Authors:  Guldeniz Karadeniz Cakmak
Journal:  Breast Care (Basel)       Date:  2021-09-16       Impact factor: 2.860

4.  The Margins' Challenge: Risk Factors of Residual Disease After Breast Conserving Surgery in Early-stage Breast Cancer.

Authors:  Piero Fregatti; Marco Gipponi; Giulia Atzori; Raffaele DE Rosa; Raquel Diaz; Chiara Cornacchia; Marco Sparavigna; Alessandro Garlaschi; Liliana Belgioia; Alessandra Fozza; Francesca Pitto; Luca Boni; Eva Blondeaux; Francesca Depaoli; Federica Murelli; Simonetta Franchelli; Gabriele Zoppoli; Matteo Lambertini; Daniele Friedman
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

5.  Socioeconomic and clinical factors affecting the proportion of breast conserving surgery in Chinese women with breast cancer.

Authors:  Jingjing Liu; Dongdong Zhou; Teng Pan; Lixia Cao; Qianxi Yang; Jin Zhang
Journal:  Gland Surg       Date:  2022-02

6.  The Factors for Success and Lack of Success in the Breast Cancer Patient Care Pathway: A Qualitative Study From the Health Care Staff Perspective.

Authors:  Eija Metsälä; Tanja Schroderus-Salo; Kjersti Straume; Bergliot Strom; Laurent Marmy; Mona Øynes; José A Pires Jorge; Liis Randle; Siret Kivistik
Journal:  Eur J Breast Health       Date:  2022-07-01

7.  Mastectomy versus breast-conservation therapy: an examination of how individual, clinicopathologic, and physician factors influence decision-making.

Authors:  J Gu; M Delisle; R Engler-Stringer; G Groot
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

8.  The Role of Sentinel Lymph Node Biopsy in Patients With B5c Breast Cancer Diagnosis.

Authors:  Piero Fregatti; Marco Gipponi; Raquel Diaz; Raffaele DE Rosa; Federica Murelli; Francesca Depaoli; Francesca Pitto; Ilaria Baldelli; Gabriele Zoppoli; Marcello Ceppi; Daniele Friedman
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

Review 9.  European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes.

Authors:  Laura Biganzoli; Lorenza Marotti; Maria-Joao Cardoso; Luigi Cataliotti; Giuseppe Curigliano; Jack Cuzick; Aaron Goldhirsch; Marjut Leidenius; Robert Mansel; Christos Markopoulos; Lynda Wyld; Isabel T Rubio
Journal:  Breast Care (Basel)       Date:  2019-10-16       Impact factor: 2.860

10.  Intraoperative fluorescence imaging with aminolevulinic acid detects grossly occult breast cancer: a phase II randomized controlled trial.

Authors:  Kathryn Ottolino-Perry; Anam Shahid; Stephanie DeLuca; Viktor Son; Mayleen Sukhram; Fannong Meng; Zhihui Amy Liu; Sara Rapic; Nayana Thalanki Anantha; Shirley C Wang; Emilie Chamma; Christopher Gibson; Philip J Medeiros; Safa Majeed; Ashley Chu; Olivia Wignall; Alessandra Pizzolato; Cheryl F Rosen; Liis Lindvere Teene; Danielle Starr-Dunham; Iris Kulbatski; Tony Panzarella; Susan J Done; Alexandra M Easson; Wey L Leong; Ralph S DaCosta
Journal:  Breast Cancer Res       Date:  2021-07-12       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.